| Breakdown | TTM | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.83B | 26.92B | 17.29B | 20.29B | 16.48B | 15.57B |
| Gross Profit | 8.14B | 10.51B | 10.76B | 13.94B | 10.36B | 9.84B |
| EBITDA | 11.65B | 13.12B | 10.48B | 13.03B | 10.02B | 9.64B |
| Net Income | 7.80B | 9.35B | 7.40B | 9.49B | 6.69B | 6.32B |
Balance Sheet | ||||||
| Total Assets | 245.49B | 244.36B | 244.76B | 231.00B | 229.97B | 227.65B |
| Cash, Cash Equivalents and Short-Term Investments | 22.51B | 27.11B | 6.86B | 6.49B | 8.70B | 9.42B |
| Total Debt | 126.64B | 124.64B | 123.76B | 114.91B | 113.11B | 111.25B |
| Total Liabilities | 142.26B | 139.58B | 138.38B | 129.00B | 127.96B | 125.23B |
| Stockholders Equity | 103.23B | 104.78B | 106.38B | 102.00B | 102.01B | 102.42B |
Cash Flow | ||||||
| Free Cash Flow | 3.32B | 15.75B | -5.28B | 5.58B | 4.55B | 3.34B |
| Operating Cash Flow | 11.86B | 18.34B | 12.23B | 17.06B | 9.80B | 8.52B |
| Investing Cash Flow | -8.10B | -2.63B | -17.19B | -11.54B | -5.19B | -5.07B |
| Financing Cash Flow | -9.05B | -10.06B | 5.81B | -7.70B | -5.24B | -6.25B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥135.97B | 17.58 | ― | 6.26% | -17.50% | -15.10% | |
66 Neutral | ¥827.41B | 22.21 | 6.59% | 3.83% | -4.44% | -3.43% | |
66 Neutral | ¥1.07T | 24.59 | 5.94% | 3.40% | -14.70% | -7.58% | |
66 Neutral | ¥117.01B | 12.15 | ― | 5.86% | -11.45% | 33.70% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | ¥217.44B | 18.01 | ― | 4.63% | 19.76% | 7.95% | |
62 Neutral | ¥297.72B | 20.70 | ― | 3.94% | 30.30% | -25.37% |